---
figid: PMC5920436__jcm-07-00062-g0A1
figlink: /pmc/articles/PMC5920436/figure/jcm-07-00062-f0A1/
number: AF1
caption: Simplified diagram of effects of BCR pathway activation. BCR activation leads
  to BTK plasma membrane translocation and phosphorylation by members of the Src kinases
  (e.g., LYN, SYK). Induction of BTK triggers activation of phospholipase C and calcium
  mobilization. This leads to downstream events such as proliferation and differentiation
  mediated through multiple transcriptions factors (NF-κB, NF-AT) and survival signaling
  cascades (RAS/RAF/MEK/ERK and PI3K/AKT/mTOR). Ibrutinib binds to BTK to inhibit
  BTK signaling.
pmcid: PMC5920436
papertitle: Novel Indications for Bruton’s Tyrosine Kinase Inhibitors, beyond Hematological
  Malignancies.
reftext: Robert Campbell, et al. J Clin Med. 2018 Apr;7(4):62.
pmc_ranked_result_index: '80648'
pathway_score: 0.8378663
filename: jcm-07-00062-g0A1.jpg
figtitle: BCR pathway activation
year: '2018'
organisms: Homo sapiens
ndex: 71ce29a9-de8e-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5920436__jcm-07-00062-g0A1.html
  '@type': Dataset
  description: Simplified diagram of effects of BCR pathway activation. BCR activation
    leads to BTK plasma membrane translocation and phosphorylation by members of the
    Src kinases (e.g., LYN, SYK). Induction of BTK triggers activation of phospholipase
    C and calcium mobilization. This leads to downstream events such as proliferation
    and differentiation mediated through multiple transcriptions factors (NF-κB, NF-AT)
    and survival signaling cascades (RAS/RAF/MEK/ERK and PI3K/AKT/mTOR). Ibrutinib
    binds to BTK to inhibit BTK signaling.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD79A
  - BTK
  - BCR
  - PIK3R3
  - NFKB1
  - NFATC2
  - LYN
  - HRAS
  - KRAS
  - AKT1
  - ARAF
  - NFAT5
  - RAF1
  - NRAS
  - AKT2
  - MAP2K1
  - SYK
  - MTOR
  - PIK3CA
  - MAPK1
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - NFATC3
  - AKT3
  - PIK3R6
  - BRAF
  - PIK3R5
  - NFATC4
  - MAPK3
  - NFATC1
  - PIK3R4
  - MAP2K2
  - Ibrutinib
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: CD79a,CD796
  symbol: CD79A
  source: hgnc_symbol
  hgnc_symbol: CD79A
  entrez: '973'
- word: BTK
  symbol: BTK
  source: hgnc_symbol
  hgnc_symbol: BTK
  entrez: '695'
- word: BCR
  symbol: BCR
  source: hgnc_symbol
  hgnc_symbol: BCR
  entrez: '613'
- word: PI3K/AKT/MTOR)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: NF-kB,
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-kB,NF-AT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC2
  entrez: '4773'
- word: LYN
  symbol: LYN
  source: hgnc_symbol
  hgnc_symbol: LYN
  entrez: '4067'
- word: (RAS/RAF/MEK/ERK
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: (RAS/RAF/MEK/ERK
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K/AKT/MTOR)
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: (RAS/RAF/MEK/ERK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: NF-kB,NF-AT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFAT5
  entrez: '10725'
- word: (RAS/RAF/MEK/ERK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: (RAS/RAF/MEK/ERK
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K/AKT/MTOR)
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: (RAS/RAF/MEK/ERK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: SYK
  symbol: SYK
  source: hgnc_symbol
  hgnc_symbol: SYK
  entrez: '6850'
- word: PI3K/AKT/MTOR)
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K/AKT/MTOR)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: (RAS/RAF/MEK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K/AKT/MTOR)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/AKT/MTOR)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/AKT/MTOR)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: NF-kB,NF-AT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC3
  entrez: '4775'
- word: PI3K/AKT/MTOR)
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K/AKT/MTOR)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: (RAS/RAF/MEK/ERK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PI3K/AKT/MTOR)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: NF-kB,NF-AT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC4
  entrez: '4776'
- word: (RAS/RAF/MEK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: NF-kB,NF-AT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC1
  entrez: '4772'
- word: PI3K/AKT/MTOR)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: (RAS/RAF/MEK/ERK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
chemicals:
- word: Ibrutinib
  source: MESH
  identifier: C551803
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC5920436__AF1
redirect_from: /figures/PMC5920436__AF1
figtype: Appendix figure
---
